Title: Make Billionaires Pay Act
Policy area: Health

Summary:
Make Billionaires Pay Act  This bill establishes a tax on the wealth increases of individuals with more than $1 billion in net assets during the COVID-19 (i.e., coronavirus disease 2019) pandemic and requires the Department of Health and Human Services (HHS) to pay the out-of-pocket expenses of individuals receiving medically-necessary care or services for a period of one year.
First, the bill requires individuals with net assets of more than $1 billion on December 31, 2020, to pay a tax of 60% on the amount equal to the lesser of (1) the increase in value of their net assets during the period beginning on March 18, 2020, through such date, or (2) the value of their net assets that is greater than $1 billion. The Department of the Treasury must establish rules for the application of this tax to married individuals and this tax is not deductible for the purpose of federal income tax.
Further, the bill covers the costs for services provided through public or private health insurance and to uninsured individuals, including prescription drugs and care related to COVID-19, for a period of one year beginning on the date of enactment of this bill. Health insurance plans are prohibited from increasing the cost-sharing requirements of plans while this program is in effect and HHS must report to Congress on the program on a weekly basis.

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8020 Introduced in House (IH)]

<DOC>






116th CONGRESS
  2d Session
                                H. R. 8020

 To impose an emergency tax on the increase in wealth of billionaires 
  during the COVID-19 pandemic in order to pay for all of the out-of-
    pocket healthcare expenses of the uninsured and under-insured, 
              including prescription drugs, for one year.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            August 11, 2020

  Ms. Omar (for herself, Mrs. Watson Coleman, Ms. Ocasio-Cortez, Ms. 
  Pressley, Ms. Tlaib, Ms. Schakowsky, Mr. Hastings, and Ms. Jayapal) 
 introduced the following bill; which was referred to the Committee on 
    Ways and Means, and in addition to the Committees on Energy and 
Commerce, Oversight and Reform, Veterans' Affairs, Armed Services, and 
 Natural Resources, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
 To impose an emergency tax on the increase in wealth of billionaires 
  during the COVID-19 pandemic in order to pay for all of the out-of-
    pocket healthcare expenses of the uninsured and under-insured, 
              including prescription drugs, for one year.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Make Billionaires Pay Act''.

                      TITLE I--PANDEMIC WEALTH TAX

SEC. 101. IMPOSITION OF PANDEMIC WEALTH TAX.

    (a) In General.--The Internal Revenue Code of 1986 is amended by 
inserting after subtitle B the following new subtitle:

                  ``Subtitle B-1--Pandemic Wealth Tax

               ``Chapter 18--Determination of Wealth Tax

               ``CHAPTER 18--DETERMINATION OF WEALTH TAX

``Sec. 2901. Imposition of tax.
``Sec. 2902. Net value of assets.
``Sec. 2903. Special rules.

``SEC. 2901. IMPOSITION OF TAX.

    ``(a) In General.--In the case of any applicable individual, there 
is hereby imposed a tax of 60 percent of the excess (if any) of--
            ``(1) the net value of assets of the applicable individual 
        on December 31, 2020, over
            ``(2) the greater of--
                    ``(A) the net value of assets of the applicable 
                individual on March 18, 2020, or
                    ``(B) $1,000,000,000.
    ``(b) Applicable Individual.--For purposes of this chapter, the 
term `applicable individual' means any individual whose assets have a 
net value on December 31, 2020, of more than $1,000,000,000.

``SEC. 2902. NET VALUE OF ASSETS.

    ``(a) In General.--The net value of assets held by an applicable 
individual as of any day shall be the excess of--
            ``(1) the value of all property of the applicable 
        individual, real or personal, tangible or intangible, wherever 
        situated, on such day, over
            ``(2) the amount of any debt owed by the applicable 
        individual on such day.
    ``(b) Inclusion of Certain Gifts.--For purposes of this subtitle, 
any property transferred by an applicable individual during the period 
described in section 2901(a) to an individual who is a member of the 
family of the applicable individual (as determined under section 
267(c)(4)) and has not attained the age of 18 shall be treated as 
property held by the taxpayer for any date before such individual 
attains the age of 18.
    ``(c) Establishment of Valuation Rules.--
            ``(1) Authority of secretary.--The Secretary shall 
        establish rules and methods for determining the value of any 
        asset for purposes of this subtitle.
            ``(2) General rules.--Except as otherwise provided in this 
        paragraph, the rules and methods established under paragraph 
        (1) may be similar to the rules of part III of subchapter A of 
        chapter 11 (other than the rules of sections 2031(c), 2032A, 
        2035, and 2044).

``SEC. 2903. SPECIAL RULES.

    ``(a) Married Individuals.--The Secretary shall by regulations 
establish rules for the application of this subtitle to married 
individuals.
    ``(b) Deceased Individuals.--In the case of any individual who dies 
during the period described in section 2901(a), section 2901(a) shall 
be applied by substituting the date of the individual's death for 
`December 31, 2020'.
    ``(c) Anti-Abuse Rules.--The Secretary shall prescribe such rules 
as necessary to prevent the avoidance of the purposes of this section, 
including through the use of trusts.''.
    (b) No Deduction From Income Taxes.--Section 275 is amended by 
inserting after paragraph (6) the following new paragraph:
            ``(7) Taxes imposed by chapter 18.''.
    (c) Clerical Amendment.--The table of subtitles is amended by 
inserting after the item relating to subtitle B the following new item:

                 ``Subtitle B-1--Pandemic Wealth Tax''.

  TITLE II--REIMBURSEMENTS FOR CERTAIN COSTS OF HEALTH CARE ITEMS AND 
 SERVICES INCLUDING PRESCRIPTION DRUGS FURNISHED DURING PUBLIC HEALTH 
                               EMERGENCY

SEC. 201. REIMBURSEMENTS FOR CERTAIN COSTS OF HEALTH CARE ITEMS AND 
              SERVICES INCLUDING PRESCRIPTION DRUGS FURNISHED DURING 
              PUBLIC HEALTH EMERGENCY.

    (a) In General.--During the 1-year period that begins on the date 
of enactment of this Act, the Secretary shall make payments to 
qualified providers with respect to applicable health care items and 
services as defined in subsection (b) that are furnished to an 
applicable individual in an amount equal to--
            (1) in the case of any portion of such period in which an 
        applicable individual is enrolled in a public or private health 
        insurance plan, the amount of any cost sharing, including any 
        deductibles, copayments, coinsurance or similar charges, that 
        would otherwise be applicable under such plan, including with 
        respect to prescription drug coverage under the plan; and
            (2) in the case of any portion of such period in which an 
        applicable individual is uninsured, the amount that would be 
        paid to the qualified provider for the same or equivalent items 
        or services, including with respect to any inpatient or 
        physician-administered drugs (and excluding outpatient 
        prescription drugs or biologicals with respect to which 
        coverage is provided under subsection (e)), under the Medicare 
        program under title XVIII of the Social Security Act (42 U.S.C. 
        1395 et seq.).
    (b) Applicable Health Care Items and Services; Applicable 
Individual Defined.--In this section:
            (1) Applicable health care items and services.--The term 
        ``applicable health care items and services'' means, with 
        respect to an applicable individual, any health care items and 
        services that are medically necessary or appropriate for the 
        maintenance of health or for the diagnosis, treatment, or 
        rehabilitation of a health condition of the applicable 
        individual, including--
                    (A) any testing services and treatments for COVID-
                19 or related complications, including vaccines, 
                diagnostic tests, drugs and biologicals, and therapies; 
                and
                    (B) in the case of an applicable individual who is 
                enrolled in a public or private health insurance plan, 
                any health care items and services covered by such plan 
                as of March 1, 2020, or in the case of an applicable 
                individual who enrolls in such plan after the date, any 
                health care items and services covered by such plan as 
                of the date of such enrollment.
            (2) Applicable individual.--The term ``applicable 
        individual'' means an individual who is a resident of the 
        United States.
    (c) Requirements.--
            (1) No effect on applicable cost-sharing requirements.--
        Nothing in this section shall affect the application of any 
        requirements applicable under Federal or State law with respect 
        to coverage of health care items and services without any cost 
        sharing.
            (2) Maintenance of effort.--
                    (A) In general.--During the period described in 
                subsection (a), a public or private health plan shall 
                not increase cost sharing, decrease benefits, or 
                otherwise make coverage less generous than the benefits 
                offered on the date of enactment of this Act.
                    (B) New items and services.--During such period, a 
                public or private health plan shall provide coverage of 
                new items and services, including those related to 
                COVID-19, as appropriate, at a minimum, at a level 
                consistent with the prior coverage practices and 
                formularies of the plan.
            (3) Limitation on out-of-pocket expenses.--During such 
        period, in order to be eligible to receive payments under this 
        section, a qualified provider shall agree not to impose on an 
        applicable individual any charge for applicable health care 
        items and services furnished to the applicable individual.
            (4) Permissible billing of plans; limitation on balance 
        billing.--During such period, in order to be eligible to 
        receive payments under this section, a qualified provider shall 
        agree, with respect to applicable health care items and 
        services furnished to an applicable individual when such 
        individual is enrolled in a public or private health insurance 
        plan--
                    (A) not to impose any charge on the plan for such 
                items and services beyond the amount otherwise payable 
                by the plan; and
                    (B) not to bill the applicable individual for any 
                amounts in excess of the amount described in 
                subparagraph (A).
            (5) Medical debt collection.--A qualified provider shall 
        agree--
                    (A) to immediately halt all medical debt 
                collection, including collection activities carried out 
                by third parties, during such period and shall not 
                collect medical debt or have third parties collect 
                medical debt for applicable health care items and 
                services furnished during such period; and
                    (B) to refrain from pursuing medical debt 
                collection, including collection activities carried out 
                by third parties, after such period with respect to 
                items and services related to the diagnosis or 
                treatment of COVID-19 (regardless of whether such 
                services were furnished before, during, or after such 
                period) and shall not collect medical debt or have 
                third parties collect medical debt for such items or 
                services after such period.
            (6) Submission of bills and documentation.--A qualified 
        provider shall agree to submit bills and any required 
        supporting documentation relating to the provision of 
        applicable health care items and services within 30 days after 
        the date of providing such services, in such manner as the 
        Secretary determines appropriate.
    (d) Waiver of Late Enrollment Penalties Under Medicare.--During the 
period described in subsection (a), no increase in the monthly premium 
of an individual pursuant to section 1818(c), 1839(b), or 1860D-13 of 
the Social Security Act (42 U.S.C. 1395i-2(c), 1395r(b), 1395w-113) 
shall be effected in the case of any individual who enrolls for 
benefits under title XVIII of such Act with respect to any period prior 
to the date of such enrollment.
    (e) Coverage With Respect to Outpatient Prescription Drugs.--
            (1) In general.--During the period described in subsection 
        (a), with respect to outpatient prescription drugs or 
        biologicals described in subsection (b)(1)(A) that are 
        dispensed to uninsured individuals, the Secretary shall 
        establish procedures under which--
                    (A) such drugs or biologicals are dispensed at no 
                cost to such individuals;
                    (B) pharmacies that dispense such drugs or 
                biologicals--
                            (i) are reimbursed by the Secretary for 
                        such drugs or biologicals dispensed to such 
                        individuals at an amount equal to the price 
                        paid by the Secretary of Veterans Affairs to 
                        procure the drug or biological under the laws 
                        administered by the Secretary of Veterans 
                        Affairs; and
                            (ii) agree not to charge such individuals 
                        for any difference between the amount 
                        reimbursed under clause (i) and the cost to the 
                        pharmacy for the drug; and
                    (C) manufacturers of such drugs or biologicals 
                reimburse pharmacies for any difference described in 
                subparagraph (B)(ii) with respect to drugs or 
                biologicals of the manufacturer that are dispensed to 
                such individuals.
            (2) Condition of coverage under medicare.--During the 
        period described in subsection (a), no coverage may be provided 
        under part B or D of title XVIII of the Social Security Act (42 
        U.S.C. 1395j et seq., 1395w-101 et seq.) with respect to a drug 
        or biological of a manufacturer if the manufacturer does not 
        enter into an agreement with the Secretary to carry out the 
        requirements applicable with respect to such manufacturers 
        under this subsection.
            (3) Requirement for participating pharmacies.--During the 
        period described in subsection (a), a prescription drug plan 
        under part D of title XVIII of the Social Security Act (42 
        U.S.C. 1395w-101 et seq.) may not contract with a pharmacy if 
        the pharmacy does not enter into an agreement with the 
        Secretary to carry out the requirements applicable with respect 
        to pharmacies under this subsection.
    (f) Other Definitions.--
            (1) Public or private health insurance plan.--
                    (A) In general.--The term ``public or private 
                health insurance plan'' means any of the following:
                            (i) A group health plan, or group health 
                        insurance coverage, as such terms are defined 
                        in section 2791 of the Public Health Service 
                        Act (42 U.S.C. 300gg-91).
                            (ii) A qualified health plan, as defined in 
                        section 1301 of the Patient Protection and 
                        Affordable Care Act (42 U.S.C. 18021).
                            (iii) Subject to subparagraph (B), any 
                        health insurance coverage (other than a plan 
                        described in clause (ii)) offered in the 
                        individual market, as such terms are defined in 
                        section 2791 of the Public Health Service Act, 
                        including any short-term limited duration 
                        insurance.
                            (iv) A health plan offered under chapter 89 
                        of title 5, United States Code.
                            (v) A Federal health care program (as 
                        defined under section 1128B(f) of the Social 
                        Security Act (42 U.S.C. 1320a-7b(f))), 
                        including--
                                    (I) health benefits furnished under 
                                the TRICARE program (as defined in 
                                section 1072 of title 10, United States 
                                Code);
                                    (II) health benefits furnished to 
                                veterans under the laws administered by 
                                the Secretary of Veterans Affairs; and
                                    (III) health benefits furnished to 
                                Indians (as defined in section 4 of the 
                                Indian Health Care Improvement Act (25 
                                U.S.C. 1603)) receiving health services 
                                through the Indian Health Service, 
                                including through an Urban Indian 
                                Organization, regardless of whether 
                                such benefits are for items or services 
                                that have been authorized under the 
                                purchased/referred care system funded 
                                by the Indian Health Service or are 
                                covered as a health service of the 
                                Indian Health Service.
                    (B) Limitation on individual health insurance 
                coverage.--The term ``public or private health 
                insurance coverage'' includes the health insurance 
                coverage described in clause (iii) of subparagraph (A) 
                only with respect to an individual who is enrolled in 
                such coverage on March 1, 2020.
            (2) Qualified provider.--The term ``qualified provider'' 
        means a health care provider who is a participating provider 
        under the Medicare program under title XVIII of the Social 
        Security Act (42 U.S.C. 1395 et seq.). Such term includes a 
        health care provider who is not a participating provider under 
        such program if the health care provider would meet the 
        criteria for such participation and, if the State requires the 
        health care provider to be licensed by the State, is licensed 
        by the State in which the items or services are furnished.
            (3) Secretary.--The term ``Secretary'' means the Secretary 
        of Health and Human Services.
    (g) Implementation.--
            (1) In general.--The Secretary, in coordination with the 
        Secretary of the Treasury, the Commissioner of Social Security, 
        and the Secretary of Labor, shall implement the provisions of 
        this section not later than the date that is 7 days after the 
        date of the enactment of this Act.
            (2) Ensuring timely payment.--The Secretary shall establish 
        a process and issue such guidance as is necessary to ensure a 
        qualified provider receives payments under this section in a 
        timely manner.
            (3) Ensuring collection of data on disparities.--The 
        Secretary shall implement this section in a manner and issue 
        such guidance as is necessary to allow for the ongoing, 
        accurate, and timely collection and analysis of data on 
        disparities in accordance with subsection (h).
    (h) Collection of Data on Disparities.--
            (1) In general.--During the period described in subsection 
        (a), the Secretary shall collect data on disparities across 
        race, ethnicity, primary language, gender, sexual orientation, 
        disability status, age, geographic area, insurance status, and 
        socioeconomic status--
                    (A) in health outcomes and access to health care 
                related to the COVID-19 outbreak, including data on 
                COVID-19 cases, treatment, and deaths; and
                    (B) in patient access to applicable health care 
                items and services under this section.
            (2) Public availability.--The Secretary shall--
                    (A) make data collected under this subsection 
                publicly available on the internet website of the 
                Department of Health and Human Services as soon as is 
                practicable, but not later than 30 days after the date 
                of enactment of this Act, in a manner that allows 
                researchers, scholars, health care providers, and 
                others to access and analyze such data, without 
                compromising patient privacy; and
                    (B) update such data on a weekly basis thereafter 
                for the duration of the period described in subsection 
                (a).
    (i) Weekly Reports to Congress.--
            (1) In general.--On a weekly basis during the period 
        described in subsection (a), the Secretary shall report to 
        Congress on--
                    (A) the implementation of this section, including 
                information on the amount, type, and geographic 
                distribution of payments to qualified providers under 
                this section; and
                    (B) any disparities in health and access to health 
                care related to the COVID-19 outbreak or patient access 
                to applicable health care items and services under this 
                section, as identified through the collection and 
                analysis of data collected under subsection (h).
            (2) Public availability.--The Secretary shall make each 
        report submitted under paragraph (1) publicly available on the 
        internet website of the Department of Health and Human 
        Services.
    (j) Funding.--There are authorized to be appropriated 
$400,000,000,000 to carry out this section.
                                 <all>